Skip to main content
. 2023 May 5;5(5):acmi000549.v2. doi: 10.1099/acmi.0.000549.v2

Table 3.

Clinical support tool

Risk factors for infection

Targeted therapeutic options*

Indwelling catheters/devices

Prolonged hospitalization

Invasive/surgical procedures

Diabetes

CKD

Chloramphenicol

Levofloxacin

Cotrimoxazole

Meropenem

Minocycline

*Sensitive in >50 % of cases in the existing literature.

CKD, chronic kidney disease.